期刊文献+

二十碳五烯酸对体外培养的人血管内皮细胞增殖抑制效应的研究 被引量:3

The inhibition effects of EPA on the proliferation of human vascular endothelial cells
原文传递
导出
摘要 目的探讨二十碳五烯酸(EPA)对体外培养的人血管内皮细胞增殖的抑制效应及其机制。方法采用四甲基偶氮唑蓝(MTT)比色法,应用酶联免疫检测仪,测定不同浓度EPA对体外培养的人血管内皮细胞吸光度(A)值的影响。采用重复测量的实验设计类型,观察EPA对体外培养的人血管内皮细胞抑制效应的剂量和时间依赖性。应用SPSS13.0软件对数据进行统计学处理。各组间A值和细胞增殖抑制率的比较,采用单因素和重复测量设计的方差分析。应用流式细胞仪检测EPA对体外培养的人血管内皮细胞周期、增殖指数及凋亡的影响,检测结果应用R×C列联表的x^2检验进行统计学分析。结果MTT比色法显示EPA浓度≥0.15g/L时,对体外培养的人血管内皮细胞A值降低的影响有统计学意义(0.15g/L EPA组与空白组比较P=0.014,0.20g/L EPA组与空白组比较P=0.001),并随时间的延长而增强,与浓度无关;对其细胞增殖抑制率的影响亦有统计学意义(0.15g/L EPA组与空白组比较P=0.02,0.20g/LEPA组与空白组比较P=0.001),且随时间的延长而增强。流式细胞仪分析结果显示,用药组细胞增殖指数为23.9%,低于未用药组(26.9%),无凋亡峰出现,表明EPA仅通过影响细胞增殖周期的变化抑制细胞增殖,无直接促进凋亡的作用。结论EPA对体外培养的人血管内皮细胞增殖具有抑制效应,该效应是通过封闭flk-1受体和影响细胞增殖周期实现;EPA对体外培养的人血管内皮细胞无直接促进凋亡的作用,因此不会对体内正常的血管内皮细胞产生损害,具有良好的临床应用前景。 Objective To investigate inhibition effects and the mechanism of EPA on the proliferation of human umbilical vascular endothelial ceils(HUVEC). Methods Different concentrations of EPA were added to the cultured HUVEC in vitro. The time cause and does response for the inhibition the cells proliferation in all groups were measured by the MTr assay, light absorption values and cytostasis ratios in all groups were compared. One-way ANOVA in the SPSS 13.0 version statistical software was used. The effect of EPA on cell cycle,proliferative index(PI) and apoptosis of HUVEC in vitro were observed by Flow Cytometry. x^2-test of R x C contingency table was used as a method for statistical analysis. Results When the concentration of EPA was equal to or more than 0.15 g/L, MTr assay showed a significant difference of light absorption value in the cultured cell after EPA exposure compared with control, the suppressing effects enhanced as the treatment time increased. The peak time of the inhibition of the cell proliferation induced by EPA was at 60 hours and the effect was last until 72 hours. The proliferative index in the treatment group was 23.9%, which was lower than that in the control group (26.9%). No apoptosis was found in the cell in each group. Conduslons EPA plays an important role of inhibition of proliferation of cultured HUVEC in vitro. No apoptosis was induced by the exposure HUVEC to EPA, therefore, it suggests a potential application for clinical trial.
出处 《中华眼科杂志》 CAS CSCD 北大核心 2007年第8期726-733,共8页 Chinese Journal of Ophthalmology
关键词 二十碳五烯酸 内皮 血管 细胞分裂 细胞凋亡 Eicosapentaenoic acid Endothelium,vascular Cell division Apoptosis
  • 相关文献

参考文献17

  • 1Poulaki V, Joussen AM, Mitsiades N, et al. Insulin-like growth factor-Ⅰ plays a pathogenetic role in diabetic retinopathy. Am J Pathol,200d, 165:457-469.
  • 2Murata M, Kador PF, Sato S, et al. Vascular endothelial growth factor(VEGF) enhances the expression of receptors and activates mitogen-activated protein (MAP) kinase of dog retinal capillary endothelial cells. J Ocular Pharmacol Therap,2000,16:383-391.
  • 3Suganami E, Takagi H, Ohashi H, et al. Leptin stimulates ischemia-induced retinal neovascularization: possible role of vascular endothelial growth factor expressed in retinal endothelial cells. Diabetes ,2004,53:2443-2448.
  • 4Ogata N, Nishikawa M, Nishimura T, et al. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. Am J Ophthalmol, 2002,134 : 348-353.
  • 5Lip PL, Belgore F, Blann AD, et al. Plasma VEGF and soluble VEGF receptor LT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment. Invest Ophthalmol & Vis Sci,2000,41:2115-2119.
  • 6Ishida S,Usui T,Yamashiro K,et al. VEGF164 is proinflammatory in the diabetic retina. Invest Ophthalmol & Vis Sci, 2003,44: 2155-2162.
  • 7Bainbridge JW, Mistry AR,Thrasher AJ, et al. Gene therapy for ocular angiogenesis. Clin Sci ,2003,104:561-575.
  • 8Ozaki H,Seo MS,Ozaki K,et al. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am J Pathol, 2000,156 : 697-707.
  • 9Zhang SX, Sima J, Shao C, et al. Plasminogen kringle 5 reduces vascular leakage in the retina in rat models of oxygen-induced retinopathy and diabetes. Diabetologia,2004,47 : 124-131.
  • 10尚雪原,张世玲,焦波,鲁凤友,程艳娜,袁玮.二十碳五烯酸抗拴作用的实验研究[J].中国海洋药物,1995,14(4):6-9. 被引量:6

二级参考文献18

  • 1Jaffe EA. Culture of human endothelial cells. Transplant Proc 1980, 12(3 suppl 1):49--53.
  • 2Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science,1989 ;246(4935) : 1306--1309.
  • 3Rosenstein JM, Mani N, Silverman WF, et al. Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo. Proc Natl Acad Sci USA,1998;95(12) : 7086--7091.
  • 4Vaisman N, Gospodarowicz D, Neufeld G. Characterization of the receptors for vascular endothelial growth factor. J Biol Chem 1990;265(32):19461--19466.
  • 5Keyt BA, Nguyen HV, Berleau LT, et al. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J Biol Chem 1996;271(10):5638--5646.
  • 6Troehon V, Mabilat C, Bertrand P, et al. Evidence of involvement of C, D44 in endotlmlial eel] proliferation, migration and angiogenesis /n,,/tro[J]. Int J Cancer, 1996, 66(5):664-668.
  • 7Risau W. Mechanisms of angiogenesis [ J ]. Nature, 1997,386(17) : 671 - 674.
  • 8Vaisman N, GoslxMarowicz D, Neufeld G. Characterization of the receptors for vascular endothelial growth factor[ J ]. J Bid Chem, 1990, 265(32): 19461 - 19466.
  • 9Keyt BA, Nguyen HV, Berleau LT, et al. Identification of vascular endothelial growth factor determinants for binding KDR and FLT- 1 receptors. Generation of receptor- selective VEGF variants by site - directed mutagenesis [ J ]. J Biol Chem, 1996, 271(10): 5638-5646.
  • 10Pober JS. Activation and injury of endothelial cells by cytokines[J]. Pathol Biol Paris, 1998, 46(3)- 159- 163.

共引文献97

同被引文献19

  • 1YANG SP, MORITA I, MUROTA SI. Eicosapentaenoic acid attenuates vascular endothelial growth factor-induced proliferation via inhibiting Flk-1 receptor expression in bovine carotid artery endothelial cells[J].J Cell Physiol, 1998,176(2) : 342-349.
  • 2HAMMES HP,WEISS A, FUHRER D, et al. Acceleration of experimental diabetic retinopathy in the rat by omega-3 fatty acids[J].Diabetologia, 1996,39 (3) : 251 - 255.
  • 3BARBER AJ, ANTONETTI DA. Mapping the blood vessels with paraeellular permeability in the retinas of diabetic rats[J]. Invest Ophthalmol Vis Sci,2003,44(12):5410-5416.
  • 4RAKOCZY PE,BRANKOV M,FONCECA A, et al. Enhanced recombinant adeno-associated virus-mediated vascular endothelial growth factor expression in the adult mouse retina: a potential model for diabetic retinopathy[J].Diabetes, 2003,52 (3) :857-863.
  • 5MORITA I. Regulation of angiogenesis-expression of VEGF receptors[J]. Hum Cell, 1998,11(4) : 215- 220.
  • 6OZAKI H, SEO MS, OZAKI K, et al. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization[J].Am J Pathol, 2000,156 (2) :697- 707.
  • 7Yang SP,Morita I, Murota SI.Eicosapentaenoic acid attenuatesvascular endothelial growth factor-induced proliferation via inhibiting Flk-1 receptor expression in bovine carotid artery endothelial ceIls[J3.J Cell Physiol, 1998,176(2) : 342- 349.
  • 8Barber AJ, Antonetti DA. Mapping the blood vessels with paracellular permeability in the retinas of diabetic rats['J~. Invest Ophthalmol Vis Sci, 2003,44 (12) : 5410- 5416.
  • 9Rakoczy PE, Brankov M, Fonceca A, et al. Enhanced recombinant adeno-associated virus-mediated vascular endothelial growth factor expression in the adult mouse retina: a potential model for diabetic retinopathy[J3.Diabetes, 2003,52 (3) :857-863.
  • 10Morita I. Regulation of angiogenesis-expression of VEGF receptorsEJ-l.Human Ce11,1998,11(4) :215-220.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部